Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

AB-2100

Aliases
Integrated Circuit T (ICT) cells

1 clinical trial

2 indications

Indication
Clear Cell Renal Cell Carcinoma
Indication
Recurrence
Clinical trial
An Open-label, Multicenter Phase 1/2 Study to Evaluate the Safety and Efficacy of AB-2100 in Patients With Recurrent Advanced or Metastatic Clear-cell Renal Cell Carcinoma (ccRCC)
Status: Recruiting, Estimated PCD: 2025-02-26